Growth Metrics

Vericel (VCEL) Return on Capital Employed Growth (3y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE Growth (3y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn -494.00
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -649.00
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 4,853.00
10 Vericel 1.69 Bn 1.55 Bn 49.27 Mn 1,106.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1,106.00
Dec 31, 2025 1,027.00
Sep 30, 2025 1,044.00
Jun 30, 2025 820.00
Mar 31, 2025 465.00
Dec 31, 2024 503.00
Sep 30, 2024 -50.00
Jun 30, 2024 -573.00
Mar 31, 2024 -341.00
Dec 31, 2023 -372.00
Sep 30, 2023 -417.00
Jun 30, 2023 -502.00
Mar 31, 2023 223.00
Dec 31, 2022 131.00
Sep 30, 2022 375.00
Jun 30, 2022 773.00
Mar 31, 2022 -285.00
Dec 31, 2021 -12.00
Sep 30, 2021 819.00
Jun 30, 2021 2,038.00
Mar 31, 2021 2,668.00
Dec 31, 2020 4,513.00
Sep 30, 2020 6,221.00
Jun 30, 2020 6,679.00
Mar 31, 2020 5,663.00
Dec 31, 2019 3,883.00
Sep 30, 2019 12,458.00
Jun 30, 2019 6,932.00
Mar 31, 2019 6,824.00
Dec 31, 2018 6,896.00
Sep 30, 2018 4,001.00
Jun 30, 2018 3,787.00
Mar 31, 2018 4,578.00
Dec 31, 2017 1,971.00
Sep 30, 2017 5,266.00
Jun 30, 2017 -105,818.00
Mar 31, 2017 47,021.00
Dec 31, 2016 34,134.00
Sep 30, 2016 126,242.00
Jun 30, 2016 57,468.00
Mar 31, 2016 30,543.00
Dec 31, 2015 18,152.00
Sep 30, 2015 12,536.00
Jun 30, 2015 9,315.00
Mar 31, 2015 345,126.00
Dec 31, 2014 -34,381.00
Sep 30, 2014 -42,433.00